US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

VBI Vaccines, Inc. - Ordinary Shares (NQ:VBIV)

0.0653 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VBI Vaccines, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
CarMax Well Positioned For Growth, Says Wedbush: Retail Sentiment Improves ↗
Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory... 
Via Stocktwits
Topics World Trade
News headline image
CarMax Shares Dive On Weak Q4 Print, But Retail Bets Trump Tariffs Will Rev Up Used Car Demand ↗
Stock fell 17%, its worst single-day decline since September 2022. 
Via Stocktwits
Topics Government World Trade
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
Via InvestorPlace
News headline image
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Dow Jumps Over 300 Points; US Trade Gap Narrows In June ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Is VBI Vaccines (VBIV) Stock Up 62% Today? ↗
VBI Vaccines stock is up on Tuesday as shares of VBIV continue to be volatile after the company filed for bankruptcy last week. 
Via InvestorPlace
Topics Bankruptcy
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! 
Via InvestorPlace
News headline image
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge ↗
 
Via Benzinga
Topics Stocks
News headline image
Dow Tumbles 950 Points; ISM Services PMI Surges In July ↗
 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views ↗
 
Via Benzinga
News headline image
VBI Vaccines Provides an Update on its Restructuring Proceedings
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBI Vaccines Announces Results of Annual General Meeting
From VBI Vaccines Inc.
Via Business Wire
News headline image
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024 ↗
VBIV stock results show that VBI Vaccines missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
VBI Vaccines Reports First Quarter 2024 Financial Results
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023 ↗
VBIV stock results show that VBI Vaccines beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
VBI Vaccines Reports Full Year 2023 Financial Results
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From VBI Vaccines Inc.
Via Business Wire
News headline image
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
Via Benzinga
News headline image
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From VBI Vaccines Inc.
Via Business Wire
News headline image
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket ↗
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning! 
Via InvestorPlace
News headline image
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
From VBI Vaccines Inc.
Via Business Wire
News headline image
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
From VBI Vaccines Inc.
Via Business Wire
News headline image
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth- 
Via Benzinga
News headline image
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list... 
Via Benzinga
News headline image
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
From VBI Vaccines Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >